The Institute of Neurosciences was created in 2015 (16th December 2015). It is a frontrunner in international neuroscience research, being one of the few institutes in the world that investigates the brain at every level. This includes research groups in neurobiology, neuropharmacology, pathophysiology, neurology, psychiatry, clinical psychology, neuropsycobiology and cognitive neurosciences.
The Institute has been awarded with the María de Maeztu Excellence Unit accreditation, and gathers about 450 researchers from the Faculties of Psychology, Medicine, Pharmacy and Biology, distributed among four university campuses (Mundet, Clínic, Bellvitge and Diagonal) in the multicultural city of Barcelona. We encourage and welcome collaboration with international research groups and organisations to boost the global vision of the Institute.
Our members enjoy benefits such as being part of a close community, learning from some of the best neuroscience researchers in the world, collaborating in both the private and public sectors, and state-of-the-art facilities.
Governing bodies
The Institute of Neurosciences is managed by a Steering Committee chosen by election among all the Institute’s members, and by a Board of Directors appointed by the Committee. This Board of Directors is constituted by the Director, the Secretary and the representatives of the six research areas. The Institute is managed according to the regulations of the University of Barcelona for research institutes, approved by the University Government Council on the 21st March 2006.
Board of Directors
Director
Dr. Jordi Alberch
Secretary
Dr. Xavier Gasull
Representatives of research areas
Dr. Josep Marco (Department of Cognition, Development and Educational Psychology)
Dr. Maria Angels Jurado (Department of Clinical Psychology and Psychobiology)
Dr. Georgina Guilera (Department of Social Psychology and Quantitative Psychology)
Dr. Raul Estévez (Department of Physiological Sciences)
Dr. Mercè Pallas Llibreria (Department of Pharmacology, Toxicology and Therapeutic Chemistry)
Dr. Yaroslau Compta (Department of Biomedicine, Clinical Neurology)
Scientific Advisory Board
Prof. Kimmo Alho, University of Helsinki, Finland
Prof. Ernest Arenas, Karolinska Institute, Sweden
Dra. Mercedes Atienza, Universidad Pablo de Olavide, Spain
Prof. Carmen Sandi, Ecole Polytechnique Federale de Lausanne, Switzerland
Dr. Frederic Saudou, Institute of Neuroscience, University Grenoble-Alps, France
